Reconstructing Consciousness and Cognition

NCT ID: NCT01911195

Last Updated: 2024-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2015-02-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Currently it is unknown how the human brain reorganizes its network organization to generate conscious experience and cognitive activity after a period of unconsciousness. Therefore, the purpose of this study is to assess how cognitive activity is reconstructed after general anesthesia. The investigators hypothesize that the brain's transition from unconsciousness to consciousness and full cognition is a complex process that occurs over an extended period of time. Specifically, the investigators hypothesize the following order of cognitive reconstitution: responsiveness to command, attention, complex scanning and visual tracking, working memory, and executive function.

Volunteers will be healthy participants who are anesthetized with commonly used anesthetic drugs as well as a non-anesthetized group to control for circadian influences. A total of 60 subjects will be recruited for this study. All subjects (male and female) will perform basic tests for cognition on a laptop computer at 30-minute intervals during this study. The testing battery to be administered was assembled to assess multiple cognitive functions in order to determine whether and how cognitive processes return to baseline function. Electroencephalogram (measuring brain electrical activity) data will be monitored and recorded during both anesthesia and cognitive testing, for subsequent analysis.

This study is significant because it could lead to a better understanding of the neural correlates of human consciousness, as well as normal and abnormal conscious state transitions (including barriers to such transitions).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Cognitive Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group: Cognitive Testing

Control arm will receive cognitive testing only without undergoing general anesthesia

Group Type ACTIVE_COMPARATOR

Control Group: Cognitive Testing

Intervention Type OTHER

The control group will undergo cognitive testing while connected to an EEG machine following a comparable rest period, but will not receive general anesthesia.

ISOFLURANE- Experimental Arm

Experimental arm will receive cognitive testing before and after general anesthesia

Group Type EXPERIMENTAL

ISOFLURANE- Experimental Arm

Intervention Type DRUG

The experimental group will be given the anesthetic isoflurane for three hours, and will undergo cognitive tests immediately following emergence from general anesthesia while connected to an EEG machine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ISOFLURANE- Experimental Arm

The experimental group will be given the anesthetic isoflurane for three hours, and will undergo cognitive tests immediately following emergence from general anesthesia while connected to an EEG machine.

Intervention Type DRUG

Control Group: Cognitive Testing

The control group will undergo cognitive testing while connected to an EEG machine following a comparable rest period, but will not receive general anesthesia.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy 20-40 year old volunteers,
* American Society of Anesthesiologists Physical Status I or II (i.e., healthy),
* Body mass index \< 30 kg/m2,
* Easily visualized uvula,
* With anticipated equal recruitment of males and females.

Exclusion Criteria

* Physical signs suggestive of difficult airway (e.g., mouth opening \<3cm, short distance between the chin and neck, poor mandibular subluxation, thick neck),
* History of obstructive sleep apnea,
* Reactive airway disease,
* Neuropsychiatric disorders,
* History or current use of psychotropic medications,
* Current tobacco and alcohol use,
* History of hypertension or current medication for blood pressure control, cardiovascular disease or arrhythmias,
* Positive urine toxicology screen,
* History of reflux,
* Pregnancy,
* Family history of problems with anesthesia (including but not limited to malignant hyperthermia),
* Sleep disorders,
* History of postoperative nausea/vomiting or motion sickness,
* Allergy to eggs, egg products or soy.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role collaborator

James S McDonnell Foundation

OTHER

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

George Mashour

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George A Mashour, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Michael Avidan, MBBCh

Role: PRINCIPAL_INVESTIGATOR

Washington University School of Medicine

Max Kelz, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Mathias Basner, MD, PhD, MSc

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Washington University in St. Louis

St Louis, Missouri, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Mashour GA, Palanca BJ, Basner M, Li D, Wang W, Blain-Moraes S, Lin N, Maier K, Muench M, Tarnal V, Vanini G, Ochroch EA, Hogg R, Schwartz M, Maybrier H, Hardie R, Janke E, Golmirzaie G, Picton P, McKinstry-Wu AR, Avidan MS, Kelz MB. Recovery of consciousness and cognition after general anesthesia in humans. Elife. 2021 May 10;10:e59525. doi: 10.7554/eLife.59525.

Reference Type BACKGROUND
PMID: 33970101 (View on PubMed)

Labonte AK, Kafashan M, Huels ER, Blain-Moraes S, Basner M, Kelz MB, Mashour GA, Avidan MS, Palanca BJA; ReCCognition Study Group. The posterior dominant rhythm: an electroencephalographic biomarker for cognitive recovery after general anaesthesia. Br J Anaesth. 2023 Feb;130(2):e233-e242. doi: 10.1016/j.bja.2022.01.019. Epub 2022 Feb 17.

Reference Type DERIVED
PMID: 35183346 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

McDonnell RCC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Essential Metal Metabolism
NCT06911515 ACTIVE_NOT_RECRUITING
Reliability of the Human Brain Connectome
NCT02193425 COMPLETED EARLY_PHASE1
Remimazolam NeuroImaging
NCT07290205 RECRUITING EARLY_PHASE1
Fenfluramine and Cognition
NCT05026398 COMPLETED PHASE4